Across the world, non-communicable diseases (NCDs) such as cancer, cardiovascular diseases, chronic respiratory illnesses, diabetes, and mental health disorders, have emerged as the leading cause of death and disability. Unlike infectious diseases, NCDs are not transmitted from person to person. They develop gradually, often influenced by genetics, lifestyle, and environmental factors.
In Saudi Arabia, NCDs accounts for 73% of all deaths, representing one of the nation’s most urgent public health challenges. As lifestyles evolves, the burden of these chronic illnesses continues to rise, demanding both preventive and therapeutic solutions.
NCDs are long-term and complex, managing them successfully requires:
Early detection and diagnosis: Through national screening programs and public awareness campaigns.
Reliable access to treatments: Ensuring the continuous supply of safe, affordable, and effective medicines.
Lifestyle modification and education: Empowering individuals to adopt healthier habits.
Innovation and local manufacturing: Enabling faster, and more affordable access to essential therapies.
By combining these elements, Saudi Arabia is transforming its healthcare system from a reactive model, one that treats disease after it occurs to a proactive, preventive one that promotes sustained wellness.
Saudi Arabia’s Ministry of Health has placed NCDs at the center of national health strategies. Initiatives under Vision 2030 emphasize early detection, healthy lifestyle promotion, and the localization of advanced pharmaceutical production.
By encouraging partnerships between local companies and global innovators, the Kingdom aims to: Strengthen its self-sufficiency in critical medicines. Expand access innovative treatments for chronic and life-threatening conditions. Build research and development capabilities within the country. These efforts reflect a shift from reactive to proactive healthcare, that not only treats disease but prevents it.
The strategy of NASMAC directly supports Vision 2030’s healthcare transformation goals by focusing on:
Healthcare self-sufficiency: Reducing dependency on imported medicines.
Knowledge transfer: Developing local expertise and manufacturing capabilities.
Patient centered innovation: Ensuring accessibility, affordability, and quality in every treatment is provided.
By addressing key therapeutic areas such as oncology, and respiratory health NASMAC contributes to shaping a healthier Saudi society.
